Focus:
News
-
22 May 2020
Roche reports additional safety data of satralizumab in NMOSD
Roche has reported new pooled safety data of its satralizumab drug to treat patients suffering from neuromyelitis optica spectrum disorder.
-
22 May 2020
UK researchers start trial of hydroxychloroquine to prevent Covid-19
Researchers at the University of Oxford in the UK are leading an international clinical trial to assess hydroxychloroquine for potentially preventing Covid-19 in frontline healthcare workers.
-
22 May 2020
Strides Pharma gets regulatory nod to trial Favipiravir in India
Strides Pharma Science has obtained approval from the Drug Controller General of India (DCGI) to conduct trials of antiviral drug Favipiravir as a potential Covid-19 treatment in the country.
-
21 May 2020
Funding secured for UK clinical trial in children with neuroblastoma
A team from the University of Birmingham will organise the UK arm of a critical European clinical trial for children diagnosed with a rare and aggressive childhood cancer called neuroblastoma.
-
21 May 2020
Gilead and Galapagos report positive Phase IIb/III filgotinib data
Gilead Sciences and Galapagos have reported positive top-line results from the Phase IIb/III SELECTION clinical trial of filgotinib for the treatment of moderately to severely active ulcerative colitis (UC).
-
21 May 2020
Octapharma to study Octagam for severe Covid-19 in US
Octapharma USA has secured regulatory approval to conduct a Phase III clinical trial of Octagam 10% for the potential treatment of Covid-19 patients with severe disease progression.
-
21 May 2020
Atea Pharmaceuticals secures clearance for Covid-19 trial
Atea Pharmaceuticals has received US Food and Drug Administration (FDA) clearance for the investigational new drug application (IND) of AT-527 for the treatment of Covid-19.
-
20 May 2020
CytoDyn and Mexican NIH to assess leronlimab for Covid-19
CytoDyn is set to collaborate with the National Institutes of Health (NIH) of Mexico to conduct a clinical trial of its CCR5 antagonist, leronlimab, to treat patients with severe/critical Covid-19.
-
20 May 2020
Philips launches HealthSuite accelerator for patient-centric trials
Royal Philips has launched Clinical Trial Accelerator on Philips HealthSuite, a customised set of capabilities that enables life science organisations to integrate, analyse and store clinical and patient-reported data drawn...
-
20 May 2020
Australian researchers trial hydroxychloroquine to prevent Covid-19
Researchers in Australia have launched a clinical trial to assess hydroxychloroquine for the prevention of Covid-19 in healthcare workers who are at high risk.